OpenVSafe by OpenVAERS
Search V-safe

R2X-42764-99525

1 vaccination 2 coded responses 5 check-ins 2 free-text entries 3 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
112 / NY
Registered
2021-01-26
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-21
    Dose 1 — Moderna
  2. 2021-01-26
    Registered in v-safe
  3. 2021-01-26
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-26
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  5. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Adult check-in
  6. 2021-01-27
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-01-28
    Health check-in — day 7, dose 1
    Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-02-13
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  9. 2021-06-08
  10. 2021-06-11
  11. 2021-06-16
  12. 2021-07-22
    Survey response — 6 months, dose 1
    MedDRA: Anovulatory cycle, Bleeding anovulatory, Uterine dilation and curettage — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Unovulatory menstrual cycle with extreme bleeding for 13 days. Had to have D&C done to stop the bleeding
    MedDRA releases: 2024-11 · check-in free text available
  13. 2021-07-22
    Report sent to call center — 6 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  14. 2021-07-28

Vaccinations

DoseDateManufacturerCo-administered
12021-01-21Moderna

Call center

ReportedOutcomeVAERS-related outcome
2021-01-26 Unsuccessful
2021-01-27 Unsuccessful
2021-07-22 Unsuccessful

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-26

Systemic reaction (other): Dizziness

Release 9 — 6 months, dose 1

2021-07-22

Symptoms: Unovulatory menstrual cycle with extreme bleeding for 13 days. Had to have D&C done to stop the bleeding

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnovulatory cycle · · ✓
SDBleeding anovulatory · · ✓
SDUterine dilation and curettage · · ✓
SRODizziness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release